Melt Pharmaceuticals Enters the Clinical Stage of MELT-100 Development
29 juil. 2020 07h00 HE
|
Melt Pharmaceuticals
FDA has accepted MELT-100 IND; Phase 1 study enrollment to start immediately BOSTON, July 29, 2020 (GLOBE NEWSWIRE) -- Melt Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing...